Every figure here is checked against the current FDA label and primary literature — education, not a pharmacy.
HealthFactLine

Fact lines for reading - not a script, not a fill. Open the line disclaimer.

Fluoxetine · practical · HFL-I3

Fluoxetine 20 mg Generic Price: Onset Weeks, Taper, and Black-Box Line

Price pages sell a cheap 20 mg capsule and stop. The US label keeps three lines that do not fit a cart: full effect may wait five weeks or longer, stopping is a planned step-down even though the drug lingers, and a boxed warning watches children, teens, and adults under 25 for new suicidal thinking. This card is the working half. How to start the 20 mg morning dose, why norfluoxetine makes missed capsules boring, how to leave without calling it a casual quit, the five-week MAOI gap, CYP2D6, and the boxed line stated without panic and without a shrug.

  • Adult start: 20 mg morning
  • Onset: 5 weeks or longer
  • Exit: planned taper
  • Box: under-25 watch
Calendar of weeks, not days, beside Prozac 20 mg capsules

The price claim vs the 20 mg start

Cheap generic fluoxetine 20 mg is a real pharmacy fact. It is not a care plan.

For adult major depression the label still opens at 20 mg once daily in the morning. For many people that dose is already the dose that works. Morning is the usual clock because the drug can activate; an evening swallow may wreck sleep. If more is needed, wait several weeks before climbing. The labeled ceiling is 80 mg a day. Doses above 20 may be once in the morning or split morning and noon.

A price comparison that never mentions the wait is a cart, not a fact line. This site's milligram lock is 20 mg because that is the adult depression start and the strength the elderly randomized pair actually tested. It is not a promise that every indication lives there. OCD, bulimia, and panic use different rungs. The evidence behind those rungs is in the depression and OCD trial file. The molecule's long tail is in the Prozac 20 mg fact line.

Five weeks or longer - the label's delay

Strike 'I gave it a week.' The OCD dosing section says the full therapeutic effect may be delayed until five weeks of treatment or longer. Depression language is the same idea: full effect may be delayed, as with other drugs in the class. Side effects do not wait. Nausea, jitter, insomnia, and a wired feeling can arrive in hours. Mood and obsession scores do not. That cruelty is ordinary SSRI pharmacology, not a sign you picked a lemon.

Counsel the mismatch on day zero or people quit in week two. Early adverse effects often fade before benefit shows. What is not an 'adjustment': a collapsing mood, new agitation, or self-harm thoughts, especially under 25 or after a dose change. Those are same-day calls, not a note to wait until week five. The boxed line below is the formal version of that watch. A cheap generic does not shorten the clock. Paying less for 20 mg still buys the same five-week wait the label printed for the brand.

The milligram ladder is not one rung

US label ranges. Not a price list and not a standing order.
IndicationUsual startWhere it often lives
Major depression (adult)20 mg morning20-80 mg; 20 mg enough for many
OCD (adult)20 mg morning20-60 mg; open work to 80
Bulimia nervosaTitrate toward 60 mg60 mg - the trial dose that beat placebo
Panic disorder10 mg morningOften 20 mg; watch early activation
Pediatric MDD / OCDOften 10 mg firstThen 20 mg; OCD may climb toward 60

Depression starts at 20 mg. OCD starts at 20 mg in adults and often lives at 40 to 60, with open work up to 80. Bulimia targets 60 mg in the morning; the trials that beat placebo used 60, not 20. Panic starts at 10 mg because early activation can look like the panic the person came in with, then rises. Premenstrual dysphoric disorder can be daily 20 mg or luteal-phase only. Pediatric depression and higher-weight pediatric OCD start lower - 10 mg is a common first step - then move toward 20.

One rule spans the ladder. Judge the dose you are actually on, after enough weeks, not the dose you wish were faster. Hepatic impairment may need a lower or less frequent schedule. The table is a map, not a self-taper kit.

Norfluoxetine is why missed doses barely move

Parent drug hangs around one to a few days. The active metabolite hangs around much longer.

Fluoxetine's half-life after chronic use is on the order of days. Norfluoxetine - itself an antidepressant - clears on the order of a week to two, sometimes quoted as four to sixteen days depending on the source table. Together they keep activity in the body for weeks after the last capsule. No other common SSRI comes close. Steady levels take weeks to build and weeks to leave.

That tail is mostly a gift for real life. Skip one morning - even two - and circulating levels barely budge. Remember later the same day, take it. If it is almost time for the next, skip the extra; do not double. Forgiving is not optional. Chronic chaos is still a worse plan than a boring daily swallow tied to breakfast or teeth. The flip side: if the drug must leave fast because of a dangerous interaction, you cannot stop today and be empty tomorrow. The five-week MAOI gap is that fact wearing a calendar.

A planned taper, even when the drug self-thins

FluoxetineShorter SSRIs (paroxetine, sertraline)
How long it hangs aroundDays to weeks with norfluoxetineRoughly a day
Stop-cold symptomsUncommon, usually mild; partial self-taperMore common if the last dose is abrupt
How to leaveStill a planned step-downUsually a slower, deliberate taper

Shorter SSRIs stopped cold can produce dizziness, electric-shock sensations, nausea, irritability, and flu-like malaise within days. Fluoxetine's long tail means those discontinuation symptoms are less common and usually milder. Some clinicians even use a fluoxetine bridge to leave a harsher exit. 'Easiest in the class' is not 'just quit because the bottle is empty.'

The larger risk when any antidepressant stops is the illness coming back, sometimes weeks later, slowly enough to miss. Leave on purpose with the prescriber who started it, after a stretch of wellness, stepping down while watching for relapse. Feeling well often means the dose is doing its job, not that you have graduated. A price page that never mentions exit is still a cart.

The five-week MAOI gap is not optional

No gray band. Fluoxetine plus a monoamine oxidase inhibitor is forbidden.

Together they can push serotonin into a syndrome of agitation, confusion, racing heart, high blood pressure, fever, rigidity, tremor, and - at the worst end - seizures or death. Stop fluoxetine and wait about five weeks before an MAOI. After an MAOI, wait fourteen days before fluoxetine. Linezolid and intravenous methylene blue sit in the same dangerous neighborhood. Thioridazine and pimozide are also contraindicated; fluoxetine can raise thioridazine and the QT risk that follows.

Other serotonergic pairs - some triptans, tramadol, other antidepressants, St. John's wort - raise the same syndrome risk without being an absolute ban. Tell every prescriber the full list. Agitation, high fever, stiffness, and a racing pulse after a medication change need urgent care, not a wait-and-see post. The FDA label is the primary text at the FDA.

The boxed line for people under 25

Antidepressants, fluoxetine included, can raise suicidal thinking and behavior in children, adolescents, and young adults, chiefly in the first weeks or after dose changes. Regulators drew that from pooled short-term trials, not from a rumor. In the same pooled look, adults older than 24 did not show an increase, and adults 65 and older showed a reduction versus placebo. No suicides occurred in the pediatric trials. Adult-trial suicides were too few to settle a drug effect on completed suicide.

The other half of the sentence has to stay attached or the box does harm. Untreated depression is itself a leading driver of suicide. Fluoxetine is specifically approved for pediatric depression from age 8 and pediatric OCD from age 7 because those rooms moved their scales. The warning is a watch plan - daily eyes from household and clinician, smallest sensible quantity on the prescription - not a reason to refuse treatment by default. Panic and shrug are both bad filings.

CYP2D6 and the list you hand over first

Fluoxetine strongly inhibits CYP2D6. Drugs that need that enzyme pile up - some tricyclics (imipramine and desipramine levels have jumped more than two- to ten-fold), some antipsychotics, flecainide, propafenone. Codeine and tramadol need CYP2D6 to become their pain-relieving forms, so fluoxetine can blunt analgesia while still adding serotonin load. Norfluoxetine keeps the enzyme blocked for weeks after the last capsule, which is why 'I stopped last Tuesday' is not a clean slate.

Hand the full medicine-and-supplement list over before capsule one. That is how you catch an MAOI, a QT drug, or a narrow-index CYP2D6 substrate. Then start 20 mg in the morning if depression is the indication, wait through the five-week clock, watch anyone under 25, and leave on a plan. Do those things and fluoxetine is a known, forgiving SSRI. How Indianapolis got to that capsule is in the Lilly long-shot file. How HAM-D and Y-BOCS moved is in the trial file.

Health Fact Line

Nine medicines, read the way a pharmacist reads a label.

Referenced monographs, a research library, and three specialists who answer the questions readers actually send.

Browse the medicines